Category: Network News

Carbohydrate ‘cage’ allows precise drug delivery to inflammation site in the gastrointestinal tract

Carbohydrate ‘cage’ allows precise drug delivery to inflammation site in the gastrointestinal tract

A GlycoCage technology developed by GlycoNet researchers aims to improve current treatments for inflammatory bowel disease

GlycoNet Investigator received McGill’s Principal’s Prize for Public Engagement Through Media

GlycoNet Investigator received McGill’s Principal’s Prize for Public Engagement Through Media

From offering policy advice to sharing his expertise on COVID-19 with the media and public, Dr. Donald Sheppard is recognized a role model with his achievement in engaging with the broader community

GlycoNet and BridgeBio Pharma Inc. initiate collaboration to discover potential treatments for genetic diseases through glycomics research

GlycoNet and BridgeBio Pharma Inc. initiate collaboration to discover potential treatments for genetic diseases through glycomics research

Genetic disease research has benefitted substantially from the study of glycomics, which relates to the functions of glycans, or sugar, in biological systems

en_USEnglish
Scroll to Top